By proceeding, you agree to our Terms of Use and Privacy Policy.
Vice President, Head of Platform Technologies
#cellgenetic #immunotherapy #biotech
#NorthAmerica
Adrian Briggs is a molecular biologist with a career focus on genetic technology, development of novel therapies and a background in biological anthropology.
Co-Founder, CEO
#immunotherapy #virus #oncolyticvirus
Aldo Pourchet is currently Co-founder at Omios Biologics
Associate Professor
#immunotherapy #investigation
#Northamerica
Dr. Andrea Facciabene’s laboratory is focused on cancer immunotherapy and the investigation of the network of immune responses to tumors, combining basic research and clinical investigation. The Facci
VP of Research and Development
#immunotherapy
I am currently a research assistant professor at the University of Houston.
Head of Research & Natural Killer Cells
#research #immunotherapy
#Middleeast
Immunotherapy expert. Skilled professional at planning experiments, interpreting research data, leading research assignments and teams. Excellent ability to learn and master new fields in biological a
Chief Scientific Officer
#oncology #celltherapy #immunotherapy #andcancerresearch
I am dedicated to making appreciable contributions to drug discovery and clinical development of novel anti-cancer agents for the benefit of patients.
#Autoimmunity #Immunotherapy #healthcare
My work has focused primarily on exploring ways to modulate T cell activity for therapeutic benefit in both autoimmune and oncology settings.
Compound Development Team Lead
#immunotherapy #preclinicaldevelopment
Immunologist with over 10 years of research experience now working in the pharmaceutical industry in the field of preclinical and discovery immuno-oncology.
#immunology #immunotherapy
A dynamic and well-published immunologist with broad expertise in the areas of vaccine development, autoimmunity and tumor immunology, Dr.
#cellanalysis #immunotherapy #immunooncology #researchdevelopment
Experienced biotechnology executive focused on life sciences tools for research, drug discovery and diagnostics specifically in the areas of immunooncology and age-related diseases.
Executive Director of Immuno-Oncology Translational Medicine
#immunology #immunoassay #immunotherapy #immunooncology
I am devoted to innovating and translating novel immunotherapies to treat metastatic cancer. In my two decades at the NCI with Steve Rosenberg and Nick Restifo, my work helped to uncover the mechanism
Global Development Lead, GI Cancers & Combinations
#immunotherapy #clinical #lungcancer
Cancer Immunotherapy, Clinical Drug Development, Novel Clinical Trials, Immune Profiling, Biomarkers, Gastrointestinal Cancers, Genitourinary Cancers, Lung Cancer, Breast Cancer, Melanoma, Immunology